Conditions: Seasonal Allergic Rhinitis
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 401
Healthy volunteers: no

Brief summary:
This study will hope to show that by relieving the participant's nasal symptoms of seasonal allergies using mometasone furoate nasal spray, the participant will obtain a better quality of night-time sleep, which in turn, causes less daytime sleepiness so that he/she can function productively during the day.

Detailed description:

Arms:
arm 1: Mometasone Furoate Nasal Spray 200 mcg, once daily. arm 2: None

Interventions: intervention 1: Mometasone Furoate Nasal Spray (MFNS) intervention 2: Placebo
Intervention descriptions: intervention 1: MFNS 50 mcg/spray: self-administered, two sprays per nostril (ie, 200 mcg QD), once daily (each morning), for 28 days. intervention 2: Matching placebo nasal spray: 2 sprays per nostril once daily for 28 days

Protocol document: